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The inactivation of staphylococcus bacteriophage by an artificially
produced anti-phagic serum was first reported by Gratia and
Jaumain", who also found that normal rabbit serum inhibits staphy
phage,-in some instances to a titer. as high as 1: 500. More re-
cently it has been observed (Rosenthal29, Raiga24 25, Biglieri and
Fischer4, Applebaum and MacNeal2, Colvin8, and Evans"0) that
normal human serum, as well as pus, possesses the power to inhibit
staphylococcus and streptococcus bacteriophages. Red blood cells
do not influence the action of either staphylococcus or coli
bacteriophage.
The early studies of d'Herelle'8 led him to state that normal
serum has no effect on bacteriophage. At that time he was chiefly
concerned with bacteriophages active against members of the enteric
group-chiefly coli and dysentery. Since it is rare to find a human
serum which inhibits coli bacteriophage, d'Herelle's statement con-
cerning the effect of serum on these phages still holds true. How-
ever, anti-coli bacteriophagic serum may be artificially produced
following the technic of Bordet and Ciuca5.
The term anti-phage, descriptive of the phage-inhibiting prin-
ciple in serum, was proposed by Sonnenschein". He observed that
normal human serum contains no anti-phage for paratyphoid B
bacteriophage, but that the serum of an individual infected with
B. paratyphosus B and the serum of a carrier of this organism were
inhibitory to the bacteriophage. He, therefore, proposed the use of
specific bacteriophage and anti-phage for diagnostic serological reac-
tions. Katsu'9 attempted to utilize this method for the diagnosis of
Flexner dysentery, but his results were tooinconsistent to be ofvalue.
Raiga2" has studied this test in connection with therapeutic failure
in cases of staphylococcus infection treated with bacteriophage. In
those individuals who failed to respond to phage given locally or
intravenously, he found in their serum anti-staphylococcus phage
antibody, and in addition a considerable amount of anti-streptococcus
phagic principle. He deduces that it is the presence of the latter
that nullifies the action of the bacteriophage. Both of these prin-
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ciples in the serum may be markedly reduced and even wiped out
by autohemotherapy. Since this anti-bacteriophagic substance is
specific, as has been shown by d'Herelle and Eliava"5, Bordet and
Ciuca5, Burnet6, Asheshov3, Schlesinger30, Kendrick20, and others,
it is not clear why streptococcus bacteriophage antibody should inter-
fere with a staphylococcus bacteriophage.
The union between bacteriophage and anti-phage is a very rapid
one, most of the phage being neutralized within 30 minutes when the
test is carried out at 370 C. (Kenidrick20, Andrewes and Elford', and
d'Herelle and Rakieten"6). Neutralization, can take place at ice-
box temperature (3 to 5° C.), but a considerable period of time must
elapse for the reaction to take place. Gratia and Mutsaars"2 and
Mutsaars" assume that the serum influences the bacteriophage
indirectly by protecting the bacteria with a colloidal coating of serum,
thereby preventing the phage from becoming adsorbed to the bac-
terial cell. Andrewes and Elford', however, postulate the presence
of a serum receptor on the bacteriophage molecule which, inde-
pendent of a secpnd receptor-that for the bacterial cell-combines
with a specific anti-phagic serum and becomes neutralized. The
union between the bacteriophage and the serum results in a blocking
of the bacterial receptor, and because of this there is failure to lyse
the bacterial cell.
It has been observed in this laboratory for the past several years
that whole blood exerts an inhibitory effect upon staphylococcus and
streptococcus phages. Recognition of this fact shows that it is prac-
tically useless to attempt isolation or production of bacteriophages
in a medium containing whole blood or serum. When serum is
necessary for the development of the bacteria, it should be tested
for the presence of anti-phage; only samples having the anti-phagic
property in small or minimal quantities being utilized.
These observations suggest that the presence of an inhibitor to
staphylococcus phage may be a matter of some importance, and it
was considered desirable to ascertain how frequently such an anti-
substance is to be encountered in sera.
Mater?als and Methods
A one per cent Savita broth was employed for the cultivation of the bac-
teria as well as for bacteriophage production. Two strains of hemolytic
Staphylococcus aureus (Sta. Pg, and Sta. Vnt) served as the phage-suscep-
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tible cultures. Stock cultures were maintained on Savita agar slants and
kept in the ice-box. For the purposes of the experiments 12- to 15-hour
broth cultures were used.
Four races of polyvalent staphylococcus phage were tested for their ability
to withstand the neutralizing effect of human sera. Bacteriophage "PG,"
which had been maintained for some three years with a single culture of
staphylococcus, "Pg," is a phage which acts particularly well in the presence
of hemolytic staphylococci. Diluted 10' to 10' it brings about complete
lysis of cultures "Pg" and "Vnt" in 6 hours at 350 C. Secondary cultures
appear after incubation for 48 hours. Bacteriophage "1OM9" has been
developed in this laboratory, several strains of staphylococci, including cultures
"Pg" and "Vnt," being used in its maintenance. This phage has also been
made what we have chosen to call "yeast-fast." Diluted 10-10 it lyses both
of the test cultures within a period of from 5 to 6 hours. Secondary culture
rarely appears. Bacteriophage "Mich," obtained from Larkum, also attacks
both of the test cultures. Bacteriophage "AP" is a polyvalent bacteriophage
which has been adapted to an artificially produced anti-phagic serum.
The sera to be tested were obtained by venepuncture of patients in the
New Haven Hospital and Dispensary, from members of the nursing and
clinical staffs, and from medical students. The sera were not inactivated by
heating and were usually used within 15 hours after collection.
The anti-phage test employed was essentially the "direct anti-phage test"
of Rosenthal29, the quantities of serum, bacteriophage, and bacteria being
those indicated below. Dilutions of serum were made with physiological
saline and to each 0.5 cc. of diluted serum an equal quantity of bacteriophage
was added. The final concentrations of serum were 1: 2, 1: 4, 1: 8, 1: 16,
and 1: 32. Two additional tubes were added to the series, one containing
0.5 cc. of bacteriophage and an equal amount of saline, the other containing
at least 0.1 cc. of serum in 10 cc. of broth. These mixtures were incubated
for 3 hours at 350 C., after which two drops from each of the first six tubes
of the series were transferred to tubes of Savita broth. To each of the broth
tubes thus inoculated, and to an additional tube of broth, 0.1 cc. of a 15-hour
broth culture of staphylococcus was added. Further incubation was at
350 C. for 18 hours.
A test was considered satisfactory only when tube 6 resulted in complete
clearing (4+ lysis) and when the control tube containing only serum and
broth showed no bacterial growth. The amount of turbidity present in tube
8 served as the standard; all tubes containing serum-phage-culture mixture
were read in terms of this tube. Those as cloudy as tube 8 indicated that
the serum had neutralized completely the lytic activity of the phage. Those
tubes that remained as clear as tube 6 indicated that no inhibition of the
phage by the serum had occurred. Readings were made after shaking the
tubes, in order to avoid error due to bacterial sedimentation.
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The serums of several patients were retested at varying intervals in order
to ascertain whether the anti-phagic substance was stable or would disappear
on standing.
Experimental
All of the sera were tested for their anti-phagic action against
bacteriophage "PG," the susceptible bacterial strain being staphylo-
coccus "Pg." The results:
TABLE I
ANTI-PHAGE TITRATION OF 200 HUMAN SERA AGAINST BACTERIOPHAGE "PG" USING
STAPHYLOCOCCUS Pg AS THE SUSCEPTIBLE STRAIN
Highest dilution
of serum showing Number History of infection
anti-phage of cases % of total absent Present
0 1 0.5 1 0
1:2 4 2.0 1 3
1:4. 15 7.5 10 5
1: 8 74 37.0 41 33
1:16 80 40.0 35 45
1:32 26 13.0 8 18
It is apparent from this table that anti-phage was demonstrated
in 199 of 200 individuals when the phage utilized was "PG" and the
susceptible culture was "Pg." Of these individuals, 84 gave no
history of ever having had a staphylococcus infection, but did have
in their serum anti-phage in a dilution of at least 1: 8. The titer of
this antibody corresponds dosely with that which one can demon-
strate against a virus disease such as poliomyelitis, and from indi-
viduals who have a negative history with regard to that disease.
Those cases listed as giving a positive history were those having
had boils, furunculosis, or infected wounds in the past, and those
showing evidence of staphylococcus infection at the time the serum
was obtained. In this latter group were people with osteomyelitis,
chronic cases of furunculosis, boils, carbuncles, paronychia, and infec-
tions following abrasions and trauma. The concentration of anti-
phage in the serum of these cases was practically the same as in the
non-infected group, both with regard to the titer and to the number
of individuals. Thus, it appears that anti-phage against staphylo-
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coccus bacteriophage is common in human sera, and that there is no
direct relationship between the concentration ofthis substance and the
presence of infection with the staphylococcus.
However, if another strain of staphylococcus (e.g., "Vnt") is
employed in the test, using the same phage, a distinct difference with
regard to the concentration of the anti-phage is observed. It may
be stated again that bacteriophage "PG" lyses equally well both
strains of staphylococcus-"Pg" and "Vnt"-in the same period of
time at the same dilution (10). Hence, the difference in the
results can not be attributed to a difference in number of corpuscles
active against "Vnt" as compared with those effective with "Pg."
The results obtained with 32 of these sera tested with bacterio-
phage "PG" and staphylococcus "Vnt" are recorded in Table II.
TABLE II
ANTI-PHAGE TITRATION OF 32 HUMAN SERA AGAINST BACTERIOPHAGE PG
USING STAPHYLOCOCCUS "Vnt" AS THE SUSCEPTIBLE STRAIN
Highest dilution
ofserumshowing Number History of infection
anti-phage of cases absent present
0 4 3 1
1:2 12 1 11
1:4 8 2 6
1:8 8 3 5
1:16 0 0 0
1:32 0 0 0
It may be observed that anti-phage was demonstrated in 28 of
these cases when the same bacteriophage was used, but with a differ-
ent bacterial host. It is significant that the highest titer reached
by any of the sera was only 1: 8, whereas in using staphylococcus
"Pg" as the host over 50 per cent of the sera had titers of at least
1:16.
In order to bring out the importance of the choice of the race
of bacteriophage as well as of the susceptible strain employed in
carrying out this test, a number of sera were tested for the presence
of phage-inhibiting substance against phage "10M9," using both
bacterial strains as hosts. This phage contained more active cor-
pusdes for both ofthese strains, since it was still fully effective when
diluted to 1010. The results are summarized.
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TABLE III
ANTI-PHAGE TITRATION OF 31 HUMAN SERA AGAINST BACTERIOPHAGE "1 0M9"
USING STAPHYLOCOCCUS Pg AS THE SUSCEPTIBLE HOST
Highest dilution
of serum showing Number History of infection
anti-phage of cases absent present
0 0 0 0
1:2 0 0 0
1:4 7 4 3
1:8 18 5 13
1:16 5 0 5
1:32 1 0 1
ANTI-PHAGE TITRATION OF 42 HUMAN SERA AGAINST BACTERIOPHAGE "10M9"
USING STAPHYLOCOCCUS "Vnt" AS THE SUSCEPTIBLE HOST
0 20 8 12
1:2 10 1 9
1:4 10 3 7
1:8 2 1 1
1:16 0 0 0
1:32 0 0 0
These results show that when staphylococcus "Pg" is used anti-
phage may be demonstrated more frequently in cases that have had a
history of infection and that when staphylococcus "Vnt" is used a
considerable number of sera have no demonstrable anti-phage regard-
less of the history of the cases. Again, it may be observed that
when strain "Pg" is employed the majority of sera have anti-phage
in a titer of 1: 8 and 1: 16, but with the employment of staphylo-
coccus "Vnt" none of the sera has inhibitory substance in a con-
centration above 1 :8.
Several of the sera were tested against four races of bacterio-
phage, using one or both strains of bacteria, this procedure being
followed because it appeared that the so-called anti-phage was not a
real substance in the serum, but simply a measure of failure of the
phage to act in the presence of serum. Phages "PG" and "Mich"
maybe termed stock polyvalent phages. Phage "1OM9" is one that
had been made yeast-fast, and phage "AP" had been adapted to an
artificially produced anti-phagic rabbit serum. Table IV illustrates
some of the results obtained when phage "PG" was used with strain
"Pg," and the other three phages with strain "Vnt."BACTERIOPHAGE INHIBITION BY SERUM
TABLE IV
ANTI-PHAGE TITRATION OF HUMAN SERUMS 100 AND 101 AGAINST PHAGES
"PG," "IOM9," "Mich," AND "AP"
History of
i4fection with Staphylo-
Serum staphylococcus Race ofphage coccus 1: 2 1: 4 1: 8 1: 16 1: 32
100 positive "PG" "Pg" 4+* 4+ 4+ 1+ 0
"10M9" "Vnt" 4+ 4+ 1+ 0 0
"Mich" "Vnt" 3+ 0 0 0 0
"AP" "Vnt" 0 0 0 0 0
101 negative "PG" "Pg" 4+ 4+ 4+ 2+ 0
"1 OM9" "Vnt" 4+ 4+ 0 0 0
"AP" "Vnt" 1+ 0 0 0 0
* 4+ = complete inhibition of phage.
It is evident that in the sera of cases 100 and 101, which are
examples of several tested under similar conditions, there is present
anti-phage active against phage "PG" when the host organism is
strain "Pg." A different idea concerning the concentration of anti-
phage in the same serum may be obtained by using a different bac-
teriophage with an organism that is just as susceptible to it as is
strain "Pg." The results obtained with bacteriophage "AP" are
interesting in that every time that this phage was employed, regard-
less of whether the host was "Pg" or "Vnt," there was very little
evidence of any anti-phage in the serum tested. In the adaptation
of this phage to an anti-phagic serum staphylococcus "Vnt" was used
as the host strain.
Many of the sera, after testing, were stored, without preservative,
in the ice-box for periods of from 3 weeks to 4 months, when they
were retested for anti-phagic action. There was no indication that
the antibody, so-called, diminished on standing, for the results with
the same phage and the same bacterial strain were the same as when
the sera were first tested. The anti-phagic antibody is as heat stable
as are agglutinins; boiling forthree minutes destroysit (Kendrick20).
The studies of d'Herelle and Eliava"5 with coli bacteriophage
and an artificially produced anti-phagic serum led to the conclusion
that the serum caused but a temporary inhibition of bacteriophage,
and that with prolonged incubation lysis of the bacteria would result.
Gratia and Jaumain11 reported that the union between phage and
serum was irreversible, and that once it occurred no lysis by the
phage took place. We examined 9 different sera using phage "PG"
and staphylococcus "Pg" for evidence on this point. Even after a
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week's incubation there was no significant clearing in any of the dilu-
tions of serum in which inhibition of phage had occurred. While
this would appear to argue against release of the phage, it can be
demonstrated by means of a plaque method that there are in those
tubes that macroscopically show little evidence of lysis, hundreds of
active corpuscles. It may be that the reason for the failure to lyse
during a prolonged period of incubation is due to the refractory state
of the bacterial cells. It must be borne in mind that lysis occurs
during the growth phase of the organisms. Even if the neutraliza-
tion between phage and serum had been disrupted the bacterial cells
themselves would be in a highly refractory state toward lysis by
the freed phage.
The presence of anti-phage seems to be in no way determined by
sex; of the 200 sera tested 113 were from males. One hundred of
the 113 samples contained anti-phage toward phage "PG" in a dilu-
tion of at least 1: 8 (42 sera, 1: 8; 44 sera, 1: 16; 26 sera, 1:32).
All of the 87 samples obtained from females contained anti-phage
(32 sera, 1: 8; 36 sera, 1:16; 12 sera, 1:32).
The recent work of Jungeblut"8 regarding age and antibody
production, particularly antibodies to poliomyelitis virus, suggested
a grouping of the cases here studied on the age basis. Table V gives
the results when the phage used was "PG."
TABLE V
DISTRIBUTION OF ANTI-PHIAGE IN HUMAN SERA (200) IN RELATION TO AGE
Highest
dilution
of serum
showing Number Age groups
anti-phage of cases 0-5 6-10 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81
0 1 0 0 0 0 1 0 0 .0 0 0
1:2 2 0 1 0 1 0 0 0 0 0 0
1:4 15 2 1 2 3 2 3 0 1 1 0
1:8 75 4 7 11 29 9 10 2 1 1 1
1:16 80 4 2 18 27 9 6 6 7 1 0
1: 32 27 0 2 5 6 4 1 3 3 2 1
Total 200 10 13 36 66 25 20 1 1 12 5 2
Obviously, the disproportion in the number of individuals in the
various age groups is so great that definite conclusions are unwar-
ranted, but it would appear that with increase in age up to 40 years
there seems to be an increase in the titer of the antibody present.
Anti-phagic substance against staphylococcus bacteriophage is also
commonly found in the serum of rabbits. Tests of the sera of 30
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rabbits of various ages showed that in 26 anti-phage active against
phage "1OM9", using staphylococcus "Vnt," was found. The con-
centration of anti-phage varied from 1: 2 to as high as 1: 512.
Obviously, if one is interested in determining the length of time that
staphylococcus phage may be demonstrated in the blood stream of
rabbits after intravenous injection, the presence of this antibody
should be considered. If it is present in demonstrable amounts the
rapid disappearance of an injected phage is readily understood.
The phage-inhibiting agent in serum is not removed by filtration
through a Chamberland L5 candle.
The artificial production of an anti-phagic serum in rabbits neces-
sarily entails the development of an anti-bacterial serum, since the
filtrate used as antigen contains dissolved bacterial protein as well
as bacteriophage. It was of interest to consider naturally occurring
anti-phage from this point of view. Table VI gives the results.
TABLE VI
RELATION BETWEEN ANTI-PHAGE TOWARD PHAGE "PG" AND AGGLUTININS FOR
STAPHYLOCOCCUS
Age of
donor
24
19
55
18
20
19
53
33
74
27
21
22
22
49
63
19
44
23
24
21
31
25
Anti-phagic
titer
1: 8
1: 8
1: 8
1:8
1: 8
1:.8
1: 32
1:8
1:4
1: 8
1: 8
1:16
1:16
1:8
1: 16
1: 8
1: 8
1: 16
1: 8
1:16
1:16
1: 8
"Pg" IN HUMAN SERUM
History of Highest dilution of serum
infection showingagglutinins
negative 1: 12
positive 0*
positive 0
positive 1: 24
negative 0
positive 1: 48
negative 1: 6
negative 0
positive 1: 48
positive 1: 6
positive 1: 20
negative 0
positive 0
negative 0
negative 0
positive 0
negative 0
negative 0
negative 0
positive 0
positive 1: 6
positive 1: 24
* No agglutination visible in any of the dilutions of serum-initial dilution 1: 6.
Serum
number
22
24
26
27
28
29
30
33
39
40
58
61
62
63
69
71
73
74
75
76
97
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These results lead to the conclusion that there is little or no
relation between the occurrence of anti-phage in human serum and
the presence ofagglutinins forstaphylococcus "Pg." Thereis, how-
ever, an apparent relation between the presence of agglutinins and a
positive history of staphylococcus infection. We have produced
rabbit anti-phagic sera, which diluted as high as 1: 3200 inhibited
the bacteriophage, although they contained agglutinins to a titer of
only 1: 400 for the susceptible strain of bacteria used in the produc-
tion ofthe phage.
Just as it is possible to adapt a staphylococcus bacteriophage to an
anti-phagic serum, so also can phage be adapted to act in the presence
of yeast. Such a phage is also able to maintain itself and multiply in
higher concentrations of human sera, pus, and egg albumin than are
stock phages.
When staphylococcus bacteriophage is placed in a medium, free
ofsugar, in which yeast cells will develop there is a marked reduction
in thecorpuscular count of thebacteriophage, although the yeast cells
themselves are not affected. If, then, a portion of the filtrate from
this mixture is allowed to develop at the expense of a susceptible
strain ofbacteria, and this phage is again placed in contact with grow-
ing yeast cells the reduction in corpuscular count is less than in the
initial contact. By repeating this procedure it is possible to produce
a phage whose corpuscular count and polyvalency remain unaffected
by contact with yeast. Coincident with this changed behaviortoward
yeast there develops an increased ability of the "yeast-fast" phage to
act in body fluids, such as blood, serum, pus, and urine. The strain
of yeast seems to be unimportant, at least, in tests made with four
varieties-a Moselle wine yeast, a top yeast, a bottom yeast, and a
bread yeast-this is true. The phage that becomes "fast" to one is
also "fast" to the others.
Some races of staphy phage acquire this yeast-fastness after only
two contacts, others require as many asseven. Yeast doesnot appear
to exert a comparable effect on either coli or dysentery phages.
These experiments with yeast, conducted in 1932 and 1933,
offered no explanation forthe peculiar adsorptive behavior of staphy
phage as contrasted with coli or dysentery phages. That the past
environmental conditions of the phages might be significant cor-
relates well with the recognized difficulty in isolating staphy phage
from materials which readily yield phages of other types. How-
ever, therecentwork ofLevine and Frisch22 suggeststhatthe adsorp-
550BACTERIOPHAGE INHIBITION BY SERUM
tion of staphy phage by yeast may be due to the presence in yeast of
staphylococcus substance. If this is true, it may well be that staphy-
lococcus phage can be adapted to withstand the adsorbing power of
this substance, for the procedure herein outlined is, in effect, a selec-
tion of only the resistant corpuscles. But whatever the explanation
may be, the fact remains that the yeast-adapted phage is more resist-
ant to serum than are stock phages. Such a yeast-fast phage ad-
ministered intravenously to individuals with a staphylococcus septi-
cemia (500 colonies per cc.) has been recovered from the blood
stream, retaining its activity in concentrations of the serum which
were inhibitory to stock phages. The two patients to whom the
phage was given died with miliary abscesses studding the liver,
spleen, and kidney, although the ante-mortem blood cultures were
sterile.
Biglieri and Fischer4 have reported the occurrence of anti-phage
against coli bacteriophage in human serum. Of the 62 human sera
which we have tested, inhibition of coli phage was noted in only
6 cases, but where present it disappeared when the sera were diluted
above 1: 2. We have never observed inhibition by either rabbit or
horse serums. The fact that anti-coli phagic substance is so rare in
serum may explain the persistence of injected phage in the blood
stream. We have recently demonstrated its presenee in the blood
stream of an individual 36 hours after it was given intravenously.
Discussion
While the presence of anti-phage, especially against staphylo-
coccus bacteriophage, has been demonstrated by several investigators,
Raiga is the chief proponent of the idea that this antibody seriously
interferes with intravenous staphylococcus bacteriophage therapy.
The theoretical basis for such an interpretation is obvious.
The experiments of Kreuger et al."1 bearing upon the persistence
of staphylococcus bacteriophage in the blood following intravenous
injection are difficult to interpret, since hi's animals (rabbits) may or
may not have had this antibody in their serum. Our studies incline
us to a belief that it is very commonly encountered in rabbit serum.
One can understandthe reason fortherapid disappearance ofstaphy-
lococcus bacteriophage in such animals, since the neutralization of
phage by serum takes place within a few minutes. Although it may
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be possible for the remaining unneutralized corpuscles to bring about
a change in the bacteria in the blood stream (d'Herelle and Bee-
croft'4, d'Herelle and Rakieten"7) one must not forget that the bac-
teria may also be multiplying and their increase may be of such mag-
nitude that bacteriophagy is improbable.
Staphylococcus anti-phage appears, under certain conditions, to'
be extremely common in human sera. These conditions, namely, the
race of bacteriophage employed together with the strain of bacteria
used as the susceptible host, may yield results that can hardly be
regarded as valid, since the same sera tested with another bacterio-
phage gives a wholly different result.
The anti-phagic action of serum may perhaps be interpreted in
another way,-as the lack of some distinctive property in the partic-
ular phage used for determination.
It is certain that the presence of anti-phage for bacteriophage
"PG" does not correlate with infection, either past or present, and
while anti-phage is more frequently found in the age groups most
likely to show antibodies toward viruses, it is probable that with
phage "PG" inhibition by serum is not related to any particular age
groups.
The facts now available suggest that there is little or no naturally
occurring anti-staphylococcus bacteriophagic substance, as such, in
human serum, but that the behavior which is termed "anti-phagic"
is really due to the disability of the particular phage to bring about
lysis in serum. It is unusual to isolate staphy phages from stool,
perhaps because of the fact that they are absorbed by many non-
specific agents. Most of the staphylococcus phages that are used
either in investigative study or for therapeutic purposes are, in the
main, old laboratory races which, although they may be able to pro-
duce complete lysis in a simple broth medium, lose this power in
the presence of serum. A phage which has been adapted to an anti-
phagic serum or has been made "yeast-fast" gains the ability to lyse
bacteria in concentrations of serum that are definitely inhibitory to
stock phages. Furthermore,.a phage that has been recovered from
the blood stream is not rendered inert by the presence of serum.
Once the phage has acquired this characteristic it retains it, without
the necessity of continued contact with yeast or serum.
Although anti-phagic activity toward phage "PG" is exhibited by
almost all sera, there does not seem to be any relation between this
property and agglutinins for the "Pg" strain of staphylococcus.
552BACTERIOPHAGE INHIBITION BY SERUM 553
Conclusions
Anti-staphylococcus bacteriophagic substance was demonstrated
in 199 of 200 human sera tested.
The presence of naturally occurring anti-staphy phagic antibody
in human sera is dependent upon (a) the race of staphylococcus bac-
teriophage employed and (b) the strain of susceptible staphylococcus
used.
Rabbit serum frequently contains inhibiting substance toward
many races of staphylococcus bacteriophage.
There does not appear to be any relationship between the pres-
ence of naturally occurring anti-staphylococcus bacteriophage anti-
body and a history of infection with staphylococcus, nor is there any
relation between naturally occurring anti-phagic antibody and the
presence of agglutinins for the staphylococcus.
The phage-inhibiting substance is heat stable at 75° C. and passes
through a Chamberland L5 candle.
At ice-box temperature it remains unchanged in concentration for
a period of at least three months.
Staphylococcus bacteriophages adapted to an artificially produced
anti-phagic serum, or adapted to withstand the destructive action
of yeast cells are only very slightly influenced, if at all, by the same
concentrations of human sera that inhibit stock -staphylococcus
bacteriophages.
The impression gained from this investigation is that there is no
naturally occurring anti-staphylococcus bacteriophagic antibody as
such, and that what is commonly so termed is in reality merely a
measure of the inability of the phage to produce lysis in particular
concentrations of serum.
Inhibiting substances toward coli bacteriophages in human or
animal sera, if present, are encountered very infrequently.
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